Jaskiran Kaur

Life sciences professional with hands-on experience in pharmacovigilance (SUSAR reporting at IQVIA) and clinical literature review (Syneos Health), combined with strong scientific writing fundamentals from an M.Sc. in Biotechnology and a PG Diploma in Clinical Research. Skilled at searching and critically interpreting biomedical literature via PubMed and related databases, and at converting complex clinical data into clear, accurate written narratives. Seeking to apply this regulatory and scientific communication background to medical writing roles spanning safety narratives, regulatory documentation, patient education materials, and medico-marketing content.

Post Graduate Biology Teacher - Guru Harkrishan Public School, hemkunt colony

(2024-07)

• Taught secondary-level science and biology, translating complex scientific concepts into clear, structured explanations for diverse learners — directly transferable to writing for lay and patient audiences.
• Developed lesson materials and assessments requiring precise, well-organized written communication, reinforcing structured content-development skills relevant to patient education and educational (IME/CME) writing.

Pharmacovigilance Officer 1 — Literature Review - Syneos Health

(2021-11 - 2022-05)

• Conducted systematic literature review across PubMed, Embase, and other biomedical databases to identify spontaneous case reports and relevant clinical publications for safety signal evaluation.
• Applied defined inclusion/exclusion criteria to assess scientific relevance of identified articles, building a rigorous foundation in evidence-based literature review — a core medical writing skill.
• Documented screening outcomes with precision and maintained audit-ready records aligned with clinical research SOPs and GCP principles.
• Gained practical exposure to how published clinical data feeds into safety narratives, aggregate reports, and regulatory submissions — directly informing the medical writing process.

Drug Safety Associate — SUSAR Reporting - IQVIA

(2021-02 - 2021-08)

Global CRO, Drug Safety & Pharmacovigilance Division

• Prepared and submitted Suspected Unexpected Serious Adverse Reaction (SUSAR) reports in compliance with ICH E2A guidelines and sponsor-specific requirements, ensuring accuracy of medical narratives within strict regulatory timelines.
• Authored structured safety narratives translating clinical case data into clear, precise regulatory language — directly analogous to medical writing for scientific and clinical audiences.
• Reviewed and assessed incoming adverse event data for reportability, coding accuracy (MedDRA), and narrative completeness, developing strong critical appraisal and medical documentation skills.
• Coordinated with medical reviewers and clinical teams to clarify case details, ensuring narrative integrity and regulatory compliance across expedited safety reporting timelines.

M.Sc. - Biotechnology - Punjabi University, Patiala (2012)

PG Diploma - Clinical Research - Apollo Hospitals AHERF (2020-08)